Meeting Report

Oral Hypomethylating Agents for Myelodysplastic Syndromes: Highlights From SOHO 2020

Allyson Price, MPAS, PA-C


J Adv Pract Oncol 2021;12(suppl 1):10-11 | https://doi.org/10.6004/jadpro.2021.12.1.13 | © 2021 Harborside™


  

ABSTRACT

Allyson Price Allyson Price, MPAS, PA-C, of The University of Texas MD Anderson Cancer Center, highlights implications for advanced practitioners from the presentation at the 2020 SOHO Annual Meeting by Guillermo Garcia-Manero, MD, also from MD Anderson Cancer Center, on the development of oral hypomethylating agents for myelodysplastic syndromes.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2021 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.